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Abstract
Background: Little is known about airway remodelling in bronchial biopsies (BB) in smokers and chronic
obstructive pulmonary disease (COPD). We conducted an initial pilot study comparing BB from COPD patients with
nonsmoking controls. This pilot study suggested the presence of reticular basement membrane (Rbm)
fragmentation and altered vessel distribution in COPD.
Methods: To determine whether Rbm fragmentation and altered vessel distribution in BB were specific for COPD
we designed a cross-sectional study and stained BB from 19 current smokers and 14 ex-smokers with mild to
moderate COPD and compared these to 15 current smokers with normal lung function and 17 healthy and
nonsmoking subjects.
Results: Thickness of the Rbm was not significantly different between groups; although in COPD this parameter
was quite variable. The Rbm showed fragmentation and splitting in both current smoking groups and ex-smoker
COPD compared with healthy nonsmokers (p < 0.02); smoking and COPD seemed to have additive effects. Rbm
fragmentation correlated with smoking history in COPD but not with age. There were more vessels in the Rbm
and fewer vessels in the lamina propria in current smokers compared to healthy nonsmokers (p < 0.05). The
number of vessels staining for vascular endothelial growth factor (VEGF) in the Rbm was higher in both current
smoker groups and ex-smoker COPD compared to healthy nonsmokers (p < 0.004). In current smoker COPD VEGF
vessel staining correlated with FEV1% predicted (r = 0.61, p < 0.02).
Conclusions: Airway remodelling in smokers and mild to moderate COPD is associated with fragmentation of the
Rbm and altered distribution of vessels in the airway wall. Rbm fragmentation was also present to as great an
extent in ex-smokers with COPD. These characteristics may have potential physiological consequences.
Background
Chronic obstructive pulmonary disease (COPD) and
asthma are both common chronic inflammatory respira-
tory diseases. COPD is a world wide problem mainly
caused by cigarette smoking. Although COPD is the
fourth most common cause of chronic disability and
mortality in developed countries and its prevalence is
increasing, little is known about structural, or remodel-
ling, changes in the airway wall and their relation to
physiology [1,2]. This contrasts with the wealth of
available data in asthma where alterations in the reticu-
lar basement membrane (Rbm) (lamina reticularis) mor-
phology and subepithelial tissue hypervascularity are
acknowledged as important features of airway wall
remodelling [3-5]. Furthermore, there have been few
reports on larger airway structural changes using bron-
chial biopsies (BB) in COPD, with most published data
relating to the lung parenchyma and small airways in
surgically resected specimens [4].
Given that COPD is also a chronic inflammatory pan-
airway disease we initially decided to study BB from
COPD subjects and compare them with nonsmoking
healthy volunteers. This preliminary study revealed Rbm
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not been previously reported. The Rbm was nonhomo-
genous in appearance and fragmented. Fragmentation
included cleft formation and splitting within the Rbm.
Vessels found in contact, penetrating and indeed com-
pletely within the Rbm. On the basis of these findings
we hypothesised that Rbm splitting and Rbm vasculari-
sation are specific features of COPD. We also hypothe-
sised that these changes may, like in asthma, [6] be
related to VEGF activity.
In this paper we report our findings on Rbm and vas-
cular remodelling in BB from COPD patients (current-
smokers and ex-smokers) and compare them with both
healthy smokers and healthy nonsmokers.
Methods
Study design
This was a cross-sectional study.
Subjects
We recruited 65 subjects through advertisement. To test
our hypotheses, we have compared BB from 17 healthy,
nonsmoking subjects (H-N),1 9c u r r e n ts m o k e r sw i t h
COPD (S-COPD) and 14 ex-smokers with COPD (ES-
COPD, all had quit for at least 6 months). To further
discriminate between smoking and disease effects we
included BB from 15 current smokers with normal lung
function (S-N).
COPD was diagnosed according to the GOLD guide-
lines [7]. Volunteers with a history of other lung diseases
were excluded. Subjects who reported exacerbations or
systemic or inhalational corticosteroid use during last 12
weeks were excluded. Patients were on symptomatic
treatment with anticholinergics when recruited and dur-
ing the study.
The study was approved by the Human Research
Ethics Committee (Tasmania) Network. All subjects pro-
vided written informed consent.
Pulmonary function tests were performed according to
the ERS/ATS guidelines [8].
Bronchoscopies were performed as previously
described [5]. Eight BB from the secondary carina of
segmental and subsegmental bronchi were obtained.
There were no complications from the procedures.
Tissue processing
4 biopsies were collected in saline of which 2 were sub-
s e q u e n t l ys n a pf r o z e ni nl i q u i dn i t r o g e n / i s o p e n t a n e
slurry and embedded in OCT for possible immunostain-
ing and the other 2 in liquid nitrogen for molecular ana-
lysis at a later date. All 4 were stored at -80°C. The
other 4 biopsies were fixed in 4% neutral buffered for-
malin for 2 hours and subsequently processed into par-
affin through graded alcohol and xylene using a Leica
ASP 200 tissue processor. Sections were cut at 3
microns from individual paraffin blocks, stained with
Haematoxylin and Eosin and morphologically assessed
for immunostaining. Blocks stained were chosen to
minimize tangential sectioning of the epithelium and to
provide greatest length of epithelium for assessment.
Two 3 micron sections from appropriate blocks were
collected on each slide being separated by a minimum
of 50 microns. Following removal of paraffin and hydra-
tion to water immunostaining for Collagen-IV (Dakocy-
tomation, Denmark, cat. no. M0785 clone CIV 22: 1/100
dilution, 90 minutes at room temp with heat retrieval)
and Vascular Endothelial Growth Factor (VEGF) (Fitz-
g e r a l d ,C o n c o r dM A .C a t .n o .1 0 R- V 1 0 1 a x :1 / 5 0 0d i l u -
tion, overnight at room temperature) was performed on
separate slides. In each case a non immune IgG1 nega-
tive control (Dakocytomation, Denmark X0931 clone
DAK-GO1) was performed to eliminate false positive
staining. Bound antibodies were elaborated using Peroxi-
dase labeled Envision + (Dakocytomation, Denmark cat.
no. K4001) and liquid DAB + (Dakocytomation, Den-
mark cat. no. K3468).
Measurements
Sections were randomized by author SW independently
of the person who examined them (AS) that was blinded
to diagnosis and order. Tissue examination was per-
formed using computer assisted image analysis tool
(Image-Pro version 5.1, Media Cybernetics, USA) at
x400 magnification. As many pictures as possible were
taken from each slide. Then 8 separate fields were ran-
domly chosen for examination.
Thickness of the Rbm was assessed by first identifying
the outer subepithelial border of the true basement
membrane and then the inner border of Rbm. The
average distance between these two borders along the
length of the Rbm within the microscopic field of vision
was then measured with the aid of automated software.
3 mm length of the Rbm was included in the
measurement.
Fragmentation of the Rbm included pieces apparently
hanging off and indeed completely separated from the
remainder, but also was associated with splitting and
formation of clefts within the Rbm (Figures 1 &2). We
have used this splitting as a quantitative measure for the
observation. The total length of splits was summated
and divided by the length of Rbm. Where the splits
were in parallel layers, all of them were included in the
measurement.
Rbm-associated vessels included those in contact with
the inner surface of the Rbm, penetrating it, or
e m b e d d e dw i t h i ni t( F i g u r e2 ) .“Vascular area” was
assessed as the area enclosed by the Collagen IV stain-
ing of the endothelial basement membrane. The area of
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and then added together. Measurements were normal-
ised by dividing by the length of Rbm.
The number and area of vessels within the LP (Figure
2) were counted to a depth of 150 micrometer from the
internal border of Rbm. Those vessels counted as Rbm
vessels were excluded. Vascular density and %vascular
area of the LP were calculated by dividing the total
number of vessels and vascular area by the total surface
area of the LP examined.
The vessels and cells stained with VEGF in the Rbm
and LP were also quantified.
Sixty three subjects had enough tissue for assessment
of VEGF and fifty nine for Collagen IV staining.
Analyses
Non-parametric ANOVA (Kruskal Wallis) and post hoc
Mann-Whitney U tests were used for testing mean dif-
ferences in variables with non-normal distribution. For
normally distributed variables ANOVA and post hoc t
tests were used. Spearman and Pearson correlation
analyses were used as indicated to test relationships. All
analyses were performed by SPSS 15 for windows. Two-
tailed p values < 0.05 were considered as significant.
Repeatability of our measurements was tested by
blinded re-examination of 12 randomly selected slides
and calculating the coefficient of repeatability for our
indices of interest by the method of Bland and Altman
[9]. This indicates what degree of change one can pick
significantly up over time or with an intervention. For
the outcomes reported here, the mean differences
between paired counts were very close to zero and we
obtained coefficients of repeatability of 33 to 94% of
the mean counts, which are comparable to or better
than previous analyses of this kind in airway biopsy
material [10]. We also tested reliability by intra-class
correlation coefficients (using ICC 3,1), which varied
from 0.83 to 0.97 and therefore are in the satisfactory
range [11].
Results
Demographics of participants are presented in Table 1.
COPD subjects were significantly older than the others
and by definition had lower FEV1% predicted, FEV1/
FVC ratio and diffusion of carbon monoxide (DLCO) %
predicted (p < 0.01).
Rbm morphology (Figure 3)
Thickness of the Rbm was not significantly different
between the four groups (p = 0.13) but was especially
variable in COPD subjects. The total length of Rbm
splits (Figures 1, 2 &3) in S-N and both COPD groups
was significantly greater than in normal controls (p <
0.02). Splits were not significantly different between S-
N, S-COPD and ES-COPD groups. Numerically, split-
ting was greatest in S-COPD, but this did not reach a
conventional level of significance.
Figure 1 Rbm splitting. Splits within the lamina reticularis (Rbm)
are indicated by black arrows. The dotted lines are examples of
how we measured splits. The borders of the Rbm are marked by
arrow-heads. (Collagen IV antibody staining, × 400).
Figure 2 Rbm vessels. A. Rbm-associated vessels (indicated by black arrows) are in close contact with, are penetrating (1) or are embedded
within (2) the Rbm. Arrow-heads point to vessels in the LP. Rbm splits are indicated again by dotted lines. B. Rbm-associated vessels (indicated
by black arrows) are embedded within the Rbm. Arrow-heads point to vessels in the LP. (Collagen IV staining, × 400).
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Both the number and area of vessels in the Rbm (Figure
2) were significantly different in current smoking groups
compared to H-N (p < 0.05) while in the ES-COPD
group vascularity was essentially normal. The area of
vessels was significantly higher in S-N than ES-COPD
and when both current smoking groups were compared
with ES-COPD (p < 0.05).
Vessels in the LP (Figure 5)
The density of vessels in the LP was significantly lower
in the two currently smoking groups compared to H-N
(p < 0.005), while ES-COPD had normal values. S-N
and both current smoking groups together had signifi-
cantly lower vascular density than ES-COPD (p < 0.01
and p < 0.02).
VEGF (Figure 6)
The number and area of vessels stained with VEGF in
the Rbm were significantly different between groups
(p < 0.004), the increase being most marked for the
S-COPD group. The proportion of vessels stained with
VEGF (ratio of vessels stained with VEGF divided by
total number of vessels) in the Rbm was significantly
higher in S-N, S-COPD and ES-COPD compared to
H-N (p < 0.006) (data not shown). There were no differ-
ences between groups in cells or vessels stained for
VEGF in the LP, nor in VEGF-stained cells in the Rbm.
Correlations
Pack-year history of smoking and splitting of the Rbm
were positively correlated (r = 0.44, p < 0.02) for the
two COPD groups (Figure 7). S-COPD group showed a
positive correlation between FEV1% predicted and ves-
sels positive for VEGF in the Rbm (r = 0.61, p < 0.02)
and also a positive correlation between vessel number in
the LP and FVC% predicted (r = 0.5, p < 0.05). We did
not find any suggestion of a relationship between age
and any of the pathological findings in any group or
combination of groups.
Discussion
This study has revealed new aspects of airway remodel-
ling in the large airways in smokers with or without
Table 1 Demographics of study group
Groups* (numbers) H-N
(17)
S-N
(15)
S-COPD
(19)
ES-COPD (14)
Age
† years 49 (20-68) 46 (30-65) 61 (46-78) 62 (53-69)
Female/Male 11/6 4/11 8/11 5/9
Pack-Years smoking
† 0 35 (11-57) 45 (18-82) 55 (18-151)
FEV1% Predicted
†‡ 119 (114-124) 100 (78-125) 83 (55-102) 83 (55-105)
FEV1/FVC% ratio
†‡ 82 (71-88) 78 (70-96) 59 (46-68) 57 (38-68)
DLCO% predicted
† ml/min/mmHg - 77 (58-105) 67 (48-83) 64 (45-74)
Number (%) with DLCO%
Predicted < 60%
- 1 (6.7%) 2 (11.2%) 4 (30.8%)
*H-N: healthy and nonsmoker, S-N: smokers with normal lung function, S-COPD and ES-COPD: smoker and ex-smoker COPD
† Median (range),
‡ post-bronchodilator values
Figure 3 Rbm thickness and splitting compared between groups. A. Rbm thickness was not different between groups (p = 0.13). B.
Compares length of splitting between groups. Bars indicate medians.
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smoking from the presence of established disease as
defined by the GOLD initiative.
Our main results may be summarised as follows:
1. Rbm thickness was not different between groups.
2. The Rbm was fragmented and had markedly
increased splitting in smokers and COPD (Figures 1
and 2), and especially in current smoking COPD.
3. The Rbm was hypervascular in smokers but not in
ES-COPD.
4. The LP was hypovascular in smokers but not in
ES-COPD.
5. Vessel staining for VEGF was increased in smo-
kers and COPD, but especially in current smokers
with COPD.
We did not find a significant difference between
groups in Rbm thickness. Previous studies have been
contradictory. One group found thicker Rbm in COPD
compared with controls, [12] with both COPD and con-
trol groups in this study being ex-smokers except for 3
COPD subjects who were never smokers. Others have
not found this difference [13,14]. We did find the Rbm
thickness to be very variable in smokers and in COPD,
and because of the fragmentation it was less easy to
quantitate accurately.
The main changes in the Rbm in smokers and COPD
were marked fragmentation and hyper-vascularisation
which are novel findings and not previously published
in the COPD literature. Rbm splitting, we propose,
could be the result of either new layers being formed by
the epithelium or more likely degradation of the Rbm
by proteolytic enzymes. Rbm splitting has been reported
previously in the glomerular basement membrane and
Figure 4 A & B. Current smokers have more vessels and larger vascular area in the Rbm. Bars indicate medians.
Figure 5 There are fewer vessels in the LP in current smokers.
Bars indicate means.
Figure 6 Vessels stained for VEGF are compared between
groups. Bars indicate medians.
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transplant rejection [15,16]. Cornell et al. proposed that
splitting is the consequence of repeated episodes of
injury with new basement membrane layers formed as
part of a repair process.
Smoking induces repeated injury to the airway epithe-
lium. As Cornell et al. proposed for kidney rejection,
this may induce epithelial repair with formation of a
new layer in the Rbm. This is compatible with the cor-
relation of smoking history and length of splitting in
our study and also explains the observed nonhomogene-
ity of the width of the Rbm in smokers.
However, the presence of splitting may well represent
a change or degradation in Rbm matrix proteins. We
believe the changes are unlikely to be an artifact of pro-
cessing as this was the same for all groups, and in pre-
vious work in asthma, where those changes are not
seen. Recently, differences in the components of col-
lagen and other proteins in the Rbm in a study compar-
ing asthma, COPD and controls have been described
[12]. Change in proteinase activity, which has been
shown in COPD, [17] may potentially explain this phe-
nomenon. The correlation of splitting with historical
amounts of smoking confirms that it is likely related to
cumulative insult to the airway mucosa.
Although COPD subjects were significantly older than
the control group, there was no correlation between age
and the length of splitting in either COPD group, ana-
lysed separately or together, nor in the S-N group. Mul-
tivariable analysis showed that age is not a predictor of
splitting (p = 0.4) but pack-year smoking history is (p <
0.02) (Table 2). The presence of splitting in ES-COPD
means we need a longitudinal study to assess whether
the Rbm is truly unable to repair itself after smoking
cessation, and to relate this to proteinase activity.
Current smokers, irrespective of their pulmonary func-
tion, had increased vessel numbers in relation to the
Rbm. This pathological change may be reversible with
smoking cessation, as ES-COPD was not different from
H-N but was different from S-N and both current smo-
ker groups taken together. Again a longitudinal smoking
cessation is now needed to confirm this and explore the
mechanisms involved. We stained a number of matched
slides with Factor VIII, which stains endothelium of
blood vessels [18], which confirmed that the structures
stained by Collagen IV were indeed vessels.
We found more vessels stained for VEGF in the Rbm
of current smokers and COPD, but VEGF staining was
most marked in current smoking COPD subjects. VEGF
is present in actively proliferating endothelium and is a
marker of active angiogenesis [19]. Therefore, we sug-
gest that angiogenesis appeared to be equally active in
COPD subjects who had quit smoking, suggesting that
it is not reversible. Again, a properly designed longitudi-
nal smoking cessation study will be necessary to confirm
this.
In contrast, we found fewer blood vessels in the LP in
current smokers, but not in ES-COPD. There have been
few previous studies investigating vascular changes in
large airway endobronchial biopsies in COPD, and none
to our knowledge that have differentiated between the
Rbm and LP. Calabrese et al. in a study on bronchosco-
pically-obtained biopsies reported more vessels in the
LP of smokers, and concluded that angiogenesis is a
part of airway remodelling in smokers. They did not
find any relationship between remodelling changes and
lung function or clinical manifestations [20]. Another
recent Italian study found larger vascular area in BB
from ex-smokers with moderate to severe COPD com-
pared to control subjects. The number of vessels was
not different between groups [21].
A potential explanation for these previous findings,
w h i c ha p p e a rt oc o n t r a s tw i t ho u ro w n ,w o u l db et h e
different selection criteria employed. For example,
Calabrese et al. recruited smokers with normal lung
function or COPD with clinical criteria of chronic bron-
chitis and they excluded subjects with emphysema.
Chronic bronchitis, which at least anecdotally is not as
prominent a feature of COPD in Australia as in Europe,
was almost completely absent in our S-N subjects
Figure 7 Length of splitting is related to pack-year smoking
history in both COPD groups taken together.
Table 2 Correlation analysis for Rbm splitting for both
COPD groups and smokers with normal lung function*
†
Regression
Coefficient
95% CI P value
Age (years) +0.36 -0.50 to +1.22 0.4
Pack-year smoking +0.43 +0.10 to +0.76 <0.02
*CI = Confidence interval
†The regressions are also adjusted for gender
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subjects with emphysema in our COPD groups (Table
1) and tried to include a “typical” local COPD popula-
tion. Zanini et al. recruited moderate to severe COPD
subjects that had quit for more than 10 years and they
did not study current smoker COPD subjects. We stu-
died COPD subjects with mild to moderate COPD. In
our study current smokers with COPD had the most
marked changes. Further, we separately counted vessels
in the Rbm and LP. However, if the Rbm- associated
vessels were added to vessels in the LP we still found
fewer vessels overall in the mucosa in current smokers
(data not shown).
There are other studies that examined airway vascu-
larity in COPD but used subjects with peripheral lung
cancer to study only smaller airways in lung resection
specimens [22,23]. Hashimoto et al. did not find any dif-
ferences in vessels in medium sized airways (internal
diameter 2-5 mm) between COPD and nonsmoking
controls, and Kuwano et al. did not find a significant
difference in vessel density in the mucosa of peripheral
airways in subjects with mild COPD compared with
controls without airway disease.
The reason for hypovascularity of the LP in smokers
in our study could not be explained on the basis of the
VEGF data produced. Pulmonary VEGF reduction in
smokers has been reported [24,25]. Hypovascularity of
the LP in current smokers may be analogous to the
observation that down-regulated VEGF within the lung
parenchyma is associated with the development of
emphysema [26,27]. Our current study did not find
reduced VEGF activity either in the Rbm or in the LP in
current smoker groups, with the percentage of vessels in
the LP staining for VEGF not being significantly differ-
ent between groups. However, an explanation for this
apparent paradox could be that VEGF is functionally
unavailable for new vessel formation in the presence of
cigarette smoke [28]. The finding of normal vessels in
ES-COPD supports this idea. More studies of the angio-
poietic system in the airways in smokers are indicated.
Deprivation of other angiogenic factors, such as angio-
poietin-1 and/or down-regulation of endothelial VEGF
receptors should also be considered and studied. What-
ever the mechanism, hypovascularity of the LP is a
smoking effect that may be reversible with quitting, but
a specific longitudinal study is needed to confirm that.
The strong relationship between Rbm vessel-related
VEGF and better FEV1% predicted in S-COPD group is
interesting. There is some evidence that some aspects of
remodelling may have a protective effect [2,29,30], and
potentially angiogenesis in the Rbm could increase air-
way stiffness and resist dynamic compression which is
frequently a physiological problem in COPD. Similarly,
the positive correlation between FVC% predicted and
the number of vessels in the LP in the S-COPD group,
probably reflecting less air trapping with more LP ves-
sels, supports this idea. However, this is likely to be a
reflection of the situation in the small airways which
were not sampled in our study. These suggestions could
be confirmed by direct assessment of airway distensibil-
ity in future studies [31]. Thus, at this stage we can not
confirm that the associations between vessel changes
and lung function are causative and further investigation
is required.
COPD groups in our study were significantly older
than H-N and S-N. However, the age range in COPD
was wide and detailed uni- and multi-variable analyses
did not suggest that age was a factor influencing the
main findings.
Conclusions
This study examined novel aspects of Rbm and vascular
remodelling in large airway biopsies in current smokers
with normal lung function and patients with established
mild to moderate COPD. Most changes seemed related
to smoking, but some were most marked in current
smoking COPD patients, suggesting additive effects in
this situation. Vessel changes may be reversible with
quitting but not Rbm fragmentation. Vascular changes
in the Rbm and LP were in opposite directions in cur-
rent smoking groups; the Rbm was hypervascular and
the LP was hypovascular. Hypervascularity of the Rbm
was associated with increased VEGF expression that
was positively related to better lung function in current
smokers with COPD. Further investigations are needed
to study the VEGF system and receptors in greater
depth, and other angiogenic factors that may contribute
to vascular remodelling and redistribution in the airways
of smokers with or without COPD. Longitudinal studies
to confirm the effects of smoking cessation and assess
disease-modifying therapy such as inhaled corticoster-
oids on airway remodelling in COPD are needed to
help clarify the pathophysiological significance of our
findings.
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